Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Rapid On-Site Anthrax Test

By HospiMedica staff writers
Posted on 08 Apr 2002
A new on-site test for the detection of anthrax in humans produces rapid test results with sufficient sensitivity to detect a potentially infectious dose.

Using actual biowarfare samples, researchers confirmed that the test achieved a reliable detection level of 4,000 spores, with 99% confidence in specificity, and substantially below the 10,000 spore level used by the US Centers for Disease Control and Prevention (CDC) to define an infectious dose. More...
The test is the product of Response Biomedical Corp. (Vancouver, Canada) and has been cleared by the US Food and Drug Administration (FDA). The system consists of a portable fluorescence reader and disposable test cartridges. The company's Ramp platform technology delivers results in less than fifteen minutes. Tests for other biologic agents, such as botulism, plague, and smallpox are also being developed by Response Biomedical.

"These independent results unequivocally show Ramp has achieved an unprecedented level of sensitivity and reliability that will vastly improve the ability to protect public health and safety against the threat of future anthrax attacks, and quickly recognize a hoax to minimize disruption,” said Bill Radvak, president and CEO of Response Biomedical.




Related Links:
Response Biomedical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.